SlideShare ist ein Scribd-Unternehmen logo
1 von 27
Management of Pre-eclampsia
and eclampsia
Case Discussions
 BACKGROUND:
 Ten percent of all pregnancies are complicated by hypertension (HTN).Eclampsia and
preeclampsia account for about half of these cases worldwide.
 DEFINITION: Eclampsia is defined as the clinical presentation of an unexplained seizure,
convulsion, or altered mental status in the setting of the signs and symptoms of
preeclampsia. It is considered a complication of severe preeclampsia.
 A woman with preeclampsia develops:
--- high blood pressure (>140 mmHg systolic or >90 mmHg diastolic)
--- protein in the urine
--- swelling (edema) of the legs, hands, face or entire body.
A25-year old 2nd gravida with a pregnancy of 28 weeks of gestation
comes for antenatal visit and on routine check up, she is found to
be having blood pressure of 150/100 mm of Hg.
 What is the diagnosis?
Repeat blood pressure measurement should be performed after 6 hours for the diagnosis of
hypertension in pregnancy.4 Urine should be checked for presence or absence of
proteinuria, diagnosis of the patient will depend on the presence or absence of the proteinuria.
If blood pressure is found to be same or > 140/ 90 mm of Hg on two occasions, 6 hours
apart without proteinuria it is gestational hypertension
If proteinuria (defined as the urinary excretion of 300 mg/L or more of protein in
a 24 hour urine collection or > 30 mg/dl or 1+ by qualitative assessment using
reagent strips) is present, it is preeclampsia, therefore proteinuria should be ruled
out by testing for urine albumin.
If patient gives history of pre-pregnancy high blood pressure, or has history of
high blood pressure before 20 weeks of gestation during this pregnancy, the diagnosis
is chronic hypertension.
If blood pressure comes to normal 6 hours later by rest, patient should be observed
carefully as there is high possibility of developing gestational hypertension
later on in pregnancy.
Elaborate the points in the history of hypertensive patients in
pregnancy which would help in the diagnosis and management
1.Age and parity: Preeclampsia often affects young and nulliparous women; whereas older women
>35 years of age are at greater risk for chronic hypertension with superimposed preeclampsia.
2.History of hypertension in family, in earlier pregnancy or prepregnancy high blood pressure: If there
is history of gestational hypertension in earlier pregnancy, there are more chances of developing
hypertension in this pregnancy, the incidence being 70%.The risk of developing preeclampsia is 20-
40% for daughters of preeclamptic mothers; 11-37% for sisters of preeclamptic women; and 22-
47% in twin sisters.
3.Race and ethinicity: Africans are more susceptible than caucasians
4.History of diabetes, thyroid disorder, anemia: These are related disorders. Both hypo- thyroidism
and hyperthyroidism are associated with hypertension.
5.History of twins, hydramnios, H.mole: would cause earlier hypertension in this pregnancy.
6.Smoking reduces the risk of preeclampsia.
What are the important points in
examination
Besides vital parameters like pulse, blood pressure, respiratory rate,
temperature, urine output, pallor, pedal edema, other important points in
examination are:
• Height, weight and BMI of the patient: obesity is more commonly
associated with preeclampsia. The relationship between maternal
weight and the risk of preeclampsia is progressive.
• Thyroid swelling: Any obvious fullness is to be noted and investigated.
• Cardiovascular system: signs of congestive cardiac failure like basal
crepitations, raised JVP, dyspnea and tachypnea have to be ruled out.
Obstetric examination: Fundal height should correspond to the period
of gestation.
 Fundal height more than period of gestation suggests twins, hydramnios,
molar pregnancy and these conditions are more commonly associated
with hypertension in pregnancy.
Fundal height less than period of gestation is suggestive of fetal growth
retardation and also may be associated with hypertension or
antihypertensive therapy, particularly atenolol
. How will you manage the above patient
First we will like to confirm the diagnosis of gestational hypertension . To
rule out severe hypertension hospitalization is advisable at least initially
for 48 hours. During this period 4 hourly blood pressure measurements
with other investigations are performed. They are as follows:
• Complete blood count including platelet count
• Urine albumin
• Liver function test
• Lactate dehydrogenase (LDH) for the diagnosis of HELLP syndrome
• PT and PTTK-Only if platelet count is abnormal
• Fundus examination to rule out severity of the
Urine albumin should be done daily by dipstick method. If the patient is confirmed to be mild
hypertensive after investigation without any organ dysfunction, she may be allowed to go home
All investigations are repeated once a week or fortnightly depending on the severity except urine
albumin and blood pressure measurement which should be done daily.
In addition to maternal investigations, fetal monitoring is also required. Fetal assessment includes
daily fetal movement count by the patient which should be more than 10 in 24 hours or more
than 3 in one hour three times a day,
 non-stress test (NST), biophysical profile, umbilical artery and cerebral artery Doppler. These
investigations are performed between 28-30 weeks of gestation initially and the biophysical
profile/NST is repeated at least once a week till patient delivers. The frequency may increase if
hypertension becomes of a severe variety or Doppler shows changes suggestive of fetal growth
restriction.
What is the role of elective cesarean delivery?
 Patients with mild disease are generally allowed vaginal delivery unless there are
obstetric indications for cesarean sections. Once severe preeclampsia is diagnosed,
labor induction and vaginal delivery have been considered ideal. Temporization
with an immature fetus is considered subsequently. Several concerns, including an
unfavorable cervix, a perceived sense of urgency because of severity of preeclampsia,
and the need to coordinate neonatal intensive care, have led some obstetricians to
advocate cesarean delivery.
What is the role of antihypertensive drugs?
Most obstetricians would like to start antihypertensive drugs after blood pressure reaches 150/100
mm of Hg thinking that these will prevent the progression of mild disease into severe disease and also
prevent the complication like severe hypertension, abruptio placentae, IUD, cardiac failure,
pulmonary edema, cerebral hemorrhage.
Methyldopa (aldomet) has been the most widely used antihypertensive drug during pregnancy and
longest followed up. It is found to be safe from the point of view of development of children later on in life,
whose mothers were administered this drug during pregnancy. It has been submitted to many controlled
trials during pregnancy and has been shown to have beneficial effects.
7 The usual starting dose is 250
mg of methyldopa three times a day. This amount may be increased up to a total of 2 gm /day
according to the patient’s response. The common side effects are postural hypotension, excessive
sedation and depression. Positive Coombs’ test and abnormal liver test are also reported.
 Calcium channel blocker like nifedipine is also being used
 Labetalol is also being used but associated with intrauterine growth retardation of the fetus
Case 2
A 32-years old multiparous woman with 32weeks of period
of gestation has come to the casualty with blood pressure
of 160/110 mm of Hg and complains of headache and
urine albumin on dipstix is 2 +.
 What is the diagnosis?
 The diagnosis of this patient is more likely of severe preeclampsia with
impending eclampsia. The diagnosis may also be that of severe pre-
eclampsia superimposed on chronic hypertension if the patient gives history of
chronic hypertension in the interval between pregnancy or before 20 weeks of
the pregnancy.
What are the additional points in the history and
examination to be looked for?
 history of excessive weight gain
 history of headache/visual disturbances like blurring of vision, bright or black
spots: suggestive of impending eclampsia
 history of epigastric pain/ right upper quadrant pain
 history of decreased urinary output
 any history of convulsion
 any history of intake of antihypertensive drugs
 any history of breathlessness/chest pain/ ghabrahat etc: suggestive of impending
cardiac failure/pulmonary edema
 any history of renal disease
In addition to examination points discussed inthe case1 of mild
hypertension mentioned earlier, following points to be noted:
1.Reflexes: Brisk deep tendon reflexes are also common and result from central nervous
system irritability. It is unusual for preeclamptic patients to have seizures without first
showing signs of nervous system irritability.
2.Fundus examination: Most common findings on fundus in severe preeclampsia are: (1)
increase in a vein to artery ratio and segmental vasospasm (2) The presence of
hemorrhage,exudates or extensive arteriolar changes suggest chronic hypertension.
(3) Papilledema is not a common finding in preeclampsia. it suggests the possibility of
a brain tumor,
Q.10. What are the main objectives of the
management?
The basic management objectives for any pregnancy complicated by
preeclampsia are:
1.Termination of pregnancy with the least possible trauma to mother and
fetus. As of now only cure for preeclampsia is the termination of
pregnancy. At best, it may be controlled only when it is of mild variety.
It is dangerous to continue pregnancy in severe preeclampsia for more
than 1-2 weeks.
2.Birth of an infant who subsequently thrives
3.Complete restoration of health to the mother
Q.11. What are the points of severity of the
disease?
What is the immediate management of this
patient?
Our aims for the immediate management of this patient are:
To bring down the blood pressure to safe levels (from severe variety
to moderate variety)
Assess general condition for presence of immediate risk factors
for convulsions (headache, altered sensorium, drowsiness,agitation,
Assessment of the fetal wellbeing and reasonable maturity
 1. Use of antihypertensive drugs, importantly intravenous labetalol or oral
nifedipine. Intravenous labetalol is used in the doses of 20 mg→40 mg→80 mg→80 mg
repeated every 10-20 minutes till a maximum dose of 220 mg. Oral nifedipine in the
doses of 10 mg→20 mg→20 mg→20 mg→20 mg may also be used upto a maximum
dose of 90 mg,with blood pressure monitoring every 10-20 minutes.8 Once the blood
pressure control is achieved ( blood pressure < 160/ 110 mm of Hg) maintenance dose
in the form of oral labetalol 100 mg twice a day (maximum up to 1200 mg) or
methyldopa 250 mg thrice a day (maximum up to 2000 mg/day) or nifedipine 10 mg
twice to thrice a day (maximum up to 80 mg) may be started. The dose of oral drug
can be titrated according to the blood pressure levels.
Use of magnesium sulphate: It is the most commonly used drug for the
prevention and treatment of eclampsia.
Magnesium sulphate is used as 4 gm (20% solution) of loading dose
intra- venously followed by 5 gm of 50% solution intramuscularly in
each buttock. Maintenance dose is 5 gm in alternate buttock 4
hourly till 24 hours after delivery
What is the expectant management in the case of
severe preeclampsia?
Most obstetricians would like to terminate the pregnancy if
reasonable maturity of fetus is present ( >32 weeks or >1 kg). Patient
has to be treated only in a tertiary care center where facility of expert
neonatologists, anaesthesiologists, senior obstetricians, O.T facility,and
blood bank facility are available. In a rare case, when period of
gestation is less than 28 weeks, to gain 1 or 2 weeks more, patient would
be observed by extremely close monitoring that is done every 2 hourly
blood pressure, urine output, general conditions (tachypnea, dyspnea,
crepts in chest) monitoring and if necessary, everyday monitoring by
investigations like hemogram with platelet count, Liver function test,
kidney function test, PT and PTTK
Patient in dangers
1.Patients throwing convulsions
2.HELLP syndrome ( 40% mortality)
3.Unannounced abruption and IUD
4.DIC
5.Cardiac complications like pulmonary edema
6.Fetal complications like intrauterine growth retardation, absent or reversed
umbilical artery Doppler, intrauterine death, neonatal death. However,
neonatal death may occur even after termination of the pregnancy.
How do we manage a patient with eclampsia?
 Check vitals
 Place patient in lateral decubitus position to prevent aspiration. The bed rails should be elevated
to prevent maternal injury. Padded tongue blade should be inserted between teeth to avoid injury to
the tongue.
 Quick history and examination.
 Keep airway clean and patent by frequent oral suctioning.
 Give oxygen by mask at 8-10 litres/minute, if convulsion occurs or pulse oximetry shows hypoxia
 Prevent convulsions further by keeping silence,dim lights, and minimal noise
 Give loading dose of magnesium sulphate, 4 gm of 20% solution intravenously slowly over 5
minutes and 5 gm of 50% solution intra- muscularly in each buttock followed by a maintenance
dose of 5 gms IM in alternate buttocks every 4 hourly till 24 hours after delivery.
 Intravenous labetalol or oral nifedipine to bring down the blood pressure to
moderate level.
 Pulse oximetry: There is possibility of help from anesthetists if patient is not
maintaining oxygen saturation on pulse oximeter
10.After the patient is stabilized, do per vaginum examination and decide termination,
preferably vaginal delivery by instilling dinoprostone gel if cervix is too
unfavorable or oxytocin augmentation in higher concentration to prevent fluid
overload (for primi patients 5 units in 500 ml of Ringer lactate
 It should be noted that cesarean section in eclampsia has higher morbidity and
mortality than vaginal delivery. However, indications of cesarean in eclampsia
sometimes can be, though rarely
 (1) obstetric indication like transverse lie, malpresentation, placenta previa, cephalo
pelvic disproportion
 (2) uncontrolled fits not responding to the anticonvulsants treatment and for
termination of pregnancy if there is no immediate prospect of vaginal delivery
inspite of induction of labor.
What are the causes of death in eclampsia
• Intracranial hemorrhage, cerebrovascular accidents
• Pulmonary edema
• Status eclampticus
• Congestive cardiac failure
• Acute renal failure/hepatic failure
• Hypertensive encephalopathy
• Acute tubular necrosis or cortical necrosis
• Disseminated intravascular coagulation (DIC)
• Hyperpyrexia due to pontine hemorrhage
• ARDS
• Aspiration pneumonitis
• All above conditions either singly or in combination.
What is the prognosis of the disease?
 The seizure characteristics of eclampsia are acute and transient and long-term
neurologic deficits are rare in patients adequately treated. However, 35% of
patients who develop eclampsia will have preeclampsia in a subsequent pregnancy.
However, recurrence of eclampsia is 1.4%.
• In women with preeclampsia in first pregnancy, the probability of recurrence in
second pregnancy is about 30% and is in inverse relation to the gestational
age at which the patient developed the disease.
• The incidence of chronic hypertension was significantly increased.
What are the complications expected in this
patient
 : Maternal complications are:
• Super imposed preeclampsia (incidence being 25%)
• Development of severe hypertension.
 Placental abruption
 Fetal complications are:
• Fetal growth restriction
• Preterm delivery and perinatal mortality
• Prone to developmental anomalies due to exposure to fetotoxic drugs like ACE inhibitors
in early pregnancy.

Weitere ähnliche Inhalte

Was ist angesagt?

Evaluation and management of hypertension in pregnancy
Evaluation and management of hypertension in pregnancyEvaluation and management of hypertension in pregnancy
Evaluation and management of hypertension in pregnancyImran Hassan
 
Preeclampsia jeevana
Preeclampsia jeevanaPreeclampsia jeevana
Preeclampsia jeevanaJeevana Ande
 
Hypertensive disorders in Pregnancy
Hypertensive disorders in PregnancyHypertensive disorders in Pregnancy
Hypertensive disorders in PregnancyTasbeeh ur Rahman
 
Protocol for MANAGEMENT OF SEVERE PRE-ECLAMPSIA/ ECLAMPSIA Green top guideli...
Protocol for MANAGEMENT OF SEVERE  PRE-ECLAMPSIA/ ECLAMPSIA Green top guideli...Protocol for MANAGEMENT OF SEVERE  PRE-ECLAMPSIA/ ECLAMPSIA Green top guideli...
Protocol for MANAGEMENT OF SEVERE PRE-ECLAMPSIA/ ECLAMPSIA Green top guideli...Aboubakr Elnashar
 
Hypertensive disorders in pregnancy by Heba
Hypertensive disorders in pregnancy by Heba Hypertensive disorders in pregnancy by Heba
Hypertensive disorders in pregnancy by Heba Heba Omoush
 
MECONIUM STAINED AMNIOTIC FLUID
MECONIUM STAINED AMNIOTIC FLUIDMECONIUM STAINED AMNIOTIC FLUID
MECONIUM STAINED AMNIOTIC FLUIDNiranjan Chavan
 
Hypertension in Pregnancy
Hypertension in PregnancyHypertension in Pregnancy
Hypertension in PregnancyDJ CrissCross
 
Hypertensive disorder in pregnancy
Hypertensive disorder in pregnancy Hypertensive disorder in pregnancy
Hypertensive disorder in pregnancy Md Shahid Iqubal
 
Pprom & prom
Pprom & promPprom & prom
Pprom & promsnich
 
Hypertensive disorders in pregnancy recent guidelines fogsi 2014
Hypertensive disorders in pregnancy recent guidelines fogsi 2014Hypertensive disorders in pregnancy recent guidelines fogsi 2014
Hypertensive disorders in pregnancy recent guidelines fogsi 2014Dr Meenakshi Sharma
 
Post Partum Hemorrhage (PPH).ppt
Post Partum Hemorrhage (PPH).pptPost Partum Hemorrhage (PPH).ppt
Post Partum Hemorrhage (PPH).pptJwan AlSofi
 
Hypertension in pregnancy ( Preeclampsia ) : recent guidelines
Hypertension in  pregnancy ( Preeclampsia ) : recent guidelinesHypertension in  pregnancy ( Preeclampsia ) : recent guidelines
Hypertension in pregnancy ( Preeclampsia ) : recent guidelinesOmar Khaled
 
Premature rupture of membranes (prom)
Premature rupture of membranes (prom)Premature rupture of membranes (prom)
Premature rupture of membranes (prom)raj kumar
 
Hypertensive Disorders in Pregnancy Update April 2019
Hypertensive Disorders in Pregnancy Update April 2019Hypertensive Disorders in Pregnancy Update April 2019
Hypertensive Disorders in Pregnancy Update April 2019Kervindran Mohanasundaram
 
Management of Preterm labor
 Management of Preterm labor Management of Preterm labor
Management of Preterm laborsunil kumar daha
 
PPH class for undergraduate
PPH class for undergraduatePPH class for undergraduate
PPH class for undergraduateDebraj Mondal
 

Was ist angesagt? (20)

Evaluation and management of hypertension in pregnancy
Evaluation and management of hypertension in pregnancyEvaluation and management of hypertension in pregnancy
Evaluation and management of hypertension in pregnancy
 
Cardiac disease in pregnancy
Cardiac disease in pregnancyCardiac disease in pregnancy
Cardiac disease in pregnancy
 
Preeclampsia jeevana
Preeclampsia jeevanaPreeclampsia jeevana
Preeclampsia jeevana
 
Hypertension in pregnancy (2)
Hypertension in pregnancy (2)Hypertension in pregnancy (2)
Hypertension in pregnancy (2)
 
Hypertensive disorders in Pregnancy
Hypertensive disorders in PregnancyHypertensive disorders in Pregnancy
Hypertensive disorders in Pregnancy
 
Protocol for MANAGEMENT OF SEVERE PRE-ECLAMPSIA/ ECLAMPSIA Green top guideli...
Protocol for MANAGEMENT OF SEVERE  PRE-ECLAMPSIA/ ECLAMPSIA Green top guideli...Protocol for MANAGEMENT OF SEVERE  PRE-ECLAMPSIA/ ECLAMPSIA Green top guideli...
Protocol for MANAGEMENT OF SEVERE PRE-ECLAMPSIA/ ECLAMPSIA Green top guideli...
 
Hypertensive disorders in pregnancy by Heba
Hypertensive disorders in pregnancy by Heba Hypertensive disorders in pregnancy by Heba
Hypertensive disorders in pregnancy by Heba
 
Ectopic pregnancy
Ectopic pregnancy Ectopic pregnancy
Ectopic pregnancy
 
MECONIUM STAINED AMNIOTIC FLUID
MECONIUM STAINED AMNIOTIC FLUIDMECONIUM STAINED AMNIOTIC FLUID
MECONIUM STAINED AMNIOTIC FLUID
 
Hypertension in Pregnancy
Hypertension in PregnancyHypertension in Pregnancy
Hypertension in Pregnancy
 
Hypertensive disorder in pregnancy
Hypertensive disorder in pregnancy Hypertensive disorder in pregnancy
Hypertensive disorder in pregnancy
 
Pprom & prom
Pprom & promPprom & prom
Pprom & prom
 
Hypertensive disorders in pregnancy recent guidelines fogsi 2014
Hypertensive disorders in pregnancy recent guidelines fogsi 2014Hypertensive disorders in pregnancy recent guidelines fogsi 2014
Hypertensive disorders in pregnancy recent guidelines fogsi 2014
 
Hyperemesis gravidarum
Hyperemesis gravidarumHyperemesis gravidarum
Hyperemesis gravidarum
 
Post Partum Hemorrhage (PPH).ppt
Post Partum Hemorrhage (PPH).pptPost Partum Hemorrhage (PPH).ppt
Post Partum Hemorrhage (PPH).ppt
 
Hypertension in pregnancy ( Preeclampsia ) : recent guidelines
Hypertension in  pregnancy ( Preeclampsia ) : recent guidelinesHypertension in  pregnancy ( Preeclampsia ) : recent guidelines
Hypertension in pregnancy ( Preeclampsia ) : recent guidelines
 
Premature rupture of membranes (prom)
Premature rupture of membranes (prom)Premature rupture of membranes (prom)
Premature rupture of membranes (prom)
 
Hypertensive Disorders in Pregnancy Update April 2019
Hypertensive Disorders in Pregnancy Update April 2019Hypertensive Disorders in Pregnancy Update April 2019
Hypertensive Disorders in Pregnancy Update April 2019
 
Management of Preterm labor
 Management of Preterm labor Management of Preterm labor
Management of Preterm labor
 
PPH class for undergraduate
PPH class for undergraduatePPH class for undergraduate
PPH class for undergraduate
 

Ähnlich wie Management of Pre-eclampsia and eclampsia Case discussions

Cardiovascular diseases of pregnancy.ppt
Cardiovascular diseases of pregnancy.pptCardiovascular diseases of pregnancy.ppt
Cardiovascular diseases of pregnancy.pptgreatdiablo
 
(Eng) pregnancy induced hypertension
(Eng) pregnancy induced hypertension(Eng) pregnancy induced hypertension
(Eng) pregnancy induced hypertensionRyan Mulyana
 
(Eng) pregnancy induced hypertension (1)
(Eng) pregnancy induced hypertension (1)(Eng) pregnancy induced hypertension (1)
(Eng) pregnancy induced hypertension (1)Ryan Mulyana
 
HYPERTENSIVE DISORDER IN PREGNANCY.pptx
HYPERTENSIVE DISORDER IN PREGNANCY.pptxHYPERTENSIVE DISORDER IN PREGNANCY.pptx
HYPERTENSIVE DISORDER IN PREGNANCY.pptxHannatAboud
 
Hypertensive disorders in pregnancy
Hypertensive disorders in pregnancyHypertensive disorders in pregnancy
Hypertensive disorders in pregnancynandita Sr. Sarah
 
Medical disorders in pregnancy
Medical disorders in pregnancyMedical disorders in pregnancy
Medical disorders in pregnancyAwoke Worku
 
Pregnancy induced hypertension
Pregnancy induced hypertensionPregnancy induced hypertension
Pregnancy induced hypertensionkasulesadat1
 
Primary Maternal Care: Hypertensive disorders of pregnancy
Primary Maternal Care: Hypertensive disorders of pregnancyPrimary Maternal Care: Hypertensive disorders of pregnancy
Primary Maternal Care: Hypertensive disorders of pregnancySaide OER Africa
 
Hypertensive disorders of pregnancy...arundev
Hypertensive disorders of pregnancy...arundevHypertensive disorders of pregnancy...arundev
Hypertensive disorders of pregnancy...arundevArundev P Nair
 
Case presentation on Pregnancy induced hypertension and diabetes.ppt
Case presentation on Pregnancy induced hypertension and diabetes.pptCase presentation on Pregnancy induced hypertension and diabetes.ppt
Case presentation on Pregnancy induced hypertension and diabetes.pptDrHamzaBaig
 
Group6-Case-Presentation.pptx
Group6-Case-Presentation.pptxGroup6-Case-Presentation.pptx
Group6-Case-Presentation.pptxReneroseTorres
 
Pregnancy with pulmonary hypertension
Pregnancy with pulmonary hypertension Pregnancy with pulmonary hypertension
Pregnancy with pulmonary hypertension dr shabnam naz shaikh
 
Tăng huyết áp thai kỳ và tiền sản giật ACOG 2019
Tăng huyết áp thai kỳ và tiền sản giật ACOG 2019Tăng huyết áp thai kỳ và tiền sản giật ACOG 2019
Tăng huyết áp thai kỳ và tiền sản giật ACOG 2019Võ Tá Sơn
 
UPDATES ON HPT DISORDERS OF PREGNANCY by dr yahya.pptx
UPDATES ON HPT DISORDERS OF PREGNANCY by dr yahya.pptxUPDATES ON HPT DISORDERS OF PREGNANCY by dr yahya.pptx
UPDATES ON HPT DISORDERS OF PREGNANCY by dr yahya.pptxMaryamYahya8
 
Hypertensive Disorders in Pregnancy.pptx
Hypertensive Disorders in Pregnancy.pptxHypertensive Disorders in Pregnancy.pptx
Hypertensive Disorders in Pregnancy.pptxNkosinathiManana2
 
preeclampsiahennawy-180207195844 3.pdf
preeclampsiahennawy-180207195844 3.pdfpreeclampsiahennawy-180207195844 3.pdf
preeclampsiahennawy-180207195844 3.pdfKubamBranndone
 
4 High risk preganancy and complications of child birth.pdf
4 High risk preganancy and complications of child birth.pdf4 High risk preganancy and complications of child birth.pdf
4 High risk preganancy and complications of child birth.pdfmeethsrivastava1
 

Ähnlich wie Management of Pre-eclampsia and eclampsia Case discussions (20)

Cardiovascular diseases of pregnancy.ppt
Cardiovascular diseases of pregnancy.pptCardiovascular diseases of pregnancy.ppt
Cardiovascular diseases of pregnancy.ppt
 
(Eng) pregnancy induced hypertension
(Eng) pregnancy induced hypertension(Eng) pregnancy induced hypertension
(Eng) pregnancy induced hypertension
 
(Eng) pregnancy induced hypertension (1)
(Eng) pregnancy induced hypertension (1)(Eng) pregnancy induced hypertension (1)
(Eng) pregnancy induced hypertension (1)
 
HYPERTENSIVE DISORDER IN PREGNANCY.pptx
HYPERTENSIVE DISORDER IN PREGNANCY.pptxHYPERTENSIVE DISORDER IN PREGNANCY.pptx
HYPERTENSIVE DISORDER IN PREGNANCY.pptx
 
Hypertensive disorders in pregnancy
Hypertensive disorders in pregnancyHypertensive disorders in pregnancy
Hypertensive disorders in pregnancy
 
Medical disorders in pregnancy
Medical disorders in pregnancyMedical disorders in pregnancy
Medical disorders in pregnancy
 
Pregnancy induced hypertension
Pregnancy induced hypertensionPregnancy induced hypertension
Pregnancy induced hypertension
 
Primary Maternal Care: Hypertensive disorders of pregnancy
Primary Maternal Care: Hypertensive disorders of pregnancyPrimary Maternal Care: Hypertensive disorders of pregnancy
Primary Maternal Care: Hypertensive disorders of pregnancy
 
Hypertensive disorders of pregnancy...arundev
Hypertensive disorders of pregnancy...arundevHypertensive disorders of pregnancy...arundev
Hypertensive disorders of pregnancy...arundev
 
Case presentation on Pregnancy induced hypertension and diabetes.ppt
Case presentation on Pregnancy induced hypertension and diabetes.pptCase presentation on Pregnancy induced hypertension and diabetes.ppt
Case presentation on Pregnancy induced hypertension and diabetes.ppt
 
Group6-Case-Presentation.pptx
Group6-Case-Presentation.pptxGroup6-Case-Presentation.pptx
Group6-Case-Presentation.pptx
 
Pregnancy with pulmonary hypertension
Pregnancy with pulmonary hypertension Pregnancy with pulmonary hypertension
Pregnancy with pulmonary hypertension
 
Tăng huyết áp thai kỳ và tiền sản giật ACOG 2019
Tăng huyết áp thai kỳ và tiền sản giật ACOG 2019Tăng huyết áp thai kỳ và tiền sản giật ACOG 2019
Tăng huyết áp thai kỳ và tiền sản giật ACOG 2019
 
UPDATES ON HPT DISORDERS OF PREGNANCY by dr yahya.pptx
UPDATES ON HPT DISORDERS OF PREGNANCY by dr yahya.pptxUPDATES ON HPT DISORDERS OF PREGNANCY by dr yahya.pptx
UPDATES ON HPT DISORDERS OF PREGNANCY by dr yahya.pptx
 
Protocol obs-edited
Protocol obs-editedProtocol obs-edited
Protocol obs-edited
 
Hypertensive Disorders in Pregnancy.pptx
Hypertensive Disorders in Pregnancy.pptxHypertensive Disorders in Pregnancy.pptx
Hypertensive Disorders in Pregnancy.pptx
 
123
123123
123
 
preeclampsiahennawy-180207195844 3.pdf
preeclampsiahennawy-180207195844 3.pdfpreeclampsiahennawy-180207195844 3.pdf
preeclampsiahennawy-180207195844 3.pdf
 
Preeclampsia
PreeclampsiaPreeclampsia
Preeclampsia
 
4 High risk preganancy and complications of child birth.pdf
4 High risk preganancy and complications of child birth.pdf4 High risk preganancy and complications of child birth.pdf
4 High risk preganancy and complications of child birth.pdf
 

Kürzlich hochgeladen

Orientation, design and principles of polyhouse
Orientation, design and principles of polyhouseOrientation, design and principles of polyhouse
Orientation, design and principles of polyhousejana861314
 
Cultivation of KODO MILLET . made by Ghanshyam pptx
Cultivation of KODO MILLET . made by Ghanshyam pptxCultivation of KODO MILLET . made by Ghanshyam pptx
Cultivation of KODO MILLET . made by Ghanshyam pptxpradhanghanshyam7136
 
All-domain Anomaly Resolution Office U.S. Department of Defense (U) Case: “Eg...
All-domain Anomaly Resolution Office U.S. Department of Defense (U) Case: “Eg...All-domain Anomaly Resolution Office U.S. Department of Defense (U) Case: “Eg...
All-domain Anomaly Resolution Office U.S. Department of Defense (U) Case: “Eg...Sérgio Sacani
 
Raman spectroscopy.pptx M Pharm, M Sc, Advanced Spectral Analysis
Raman spectroscopy.pptx M Pharm, M Sc, Advanced Spectral AnalysisRaman spectroscopy.pptx M Pharm, M Sc, Advanced Spectral Analysis
Raman spectroscopy.pptx M Pharm, M Sc, Advanced Spectral AnalysisDiwakar Mishra
 
Disentangling the origin of chemical differences using GHOST
Disentangling the origin of chemical differences using GHOSTDisentangling the origin of chemical differences using GHOST
Disentangling the origin of chemical differences using GHOSTSérgio Sacani
 
Botany krishna series 2nd semester Only Mcq type questions
Botany krishna series 2nd semester Only Mcq type questionsBotany krishna series 2nd semester Only Mcq type questions
Botany krishna series 2nd semester Only Mcq type questionsSumit Kumar yadav
 
Nightside clouds and disequilibrium chemistry on the hot Jupiter WASP-43b
Nightside clouds and disequilibrium chemistry on the hot Jupiter WASP-43bNightside clouds and disequilibrium chemistry on the hot Jupiter WASP-43b
Nightside clouds and disequilibrium chemistry on the hot Jupiter WASP-43bSérgio Sacani
 
Recombinant DNA technology (Immunological screening)
Recombinant DNA technology (Immunological screening)Recombinant DNA technology (Immunological screening)
Recombinant DNA technology (Immunological screening)PraveenaKalaiselvan1
 
Botany 4th semester series (krishna).pdf
Botany 4th semester series (krishna).pdfBotany 4th semester series (krishna).pdf
Botany 4th semester series (krishna).pdfSumit Kumar yadav
 
Labelling Requirements and Label Claims for Dietary Supplements and Recommend...
Labelling Requirements and Label Claims for Dietary Supplements and Recommend...Labelling Requirements and Label Claims for Dietary Supplements and Recommend...
Labelling Requirements and Label Claims for Dietary Supplements and Recommend...Lokesh Kothari
 
VIRUSES structure and classification ppt by Dr.Prince C P
VIRUSES structure and classification ppt by Dr.Prince C PVIRUSES structure and classification ppt by Dr.Prince C P
VIRUSES structure and classification ppt by Dr.Prince C PPRINCE C P
 
GBSN - Microbiology (Unit 1)
GBSN - Microbiology (Unit 1)GBSN - Microbiology (Unit 1)
GBSN - Microbiology (Unit 1)Areesha Ahmad
 
Presentation Vikram Lander by Vedansh Gupta.pptx
Presentation Vikram Lander by Vedansh Gupta.pptxPresentation Vikram Lander by Vedansh Gupta.pptx
Presentation Vikram Lander by Vedansh Gupta.pptxgindu3009
 
DIFFERENCE IN BACK CROSS AND TEST CROSS
DIFFERENCE IN  BACK CROSS AND TEST CROSSDIFFERENCE IN  BACK CROSS AND TEST CROSS
DIFFERENCE IN BACK CROSS AND TEST CROSSLeenakshiTyagi
 
STERILITY TESTING OF PHARMACEUTICALS ppt by DR.C.P.PRINCE
STERILITY TESTING OF PHARMACEUTICALS ppt by DR.C.P.PRINCESTERILITY TESTING OF PHARMACEUTICALS ppt by DR.C.P.PRINCE
STERILITY TESTING OF PHARMACEUTICALS ppt by DR.C.P.PRINCEPRINCE C P
 
Broad bean, Lima Bean, Jack bean, Ullucus.pptx
Broad bean, Lima Bean, Jack bean, Ullucus.pptxBroad bean, Lima Bean, Jack bean, Ullucus.pptx
Broad bean, Lima Bean, Jack bean, Ullucus.pptxjana861314
 
GBSN - Microbiology (Unit 2)
GBSN - Microbiology (Unit 2)GBSN - Microbiology (Unit 2)
GBSN - Microbiology (Unit 2)Areesha Ahmad
 
Unlocking the Potential: Deep dive into ocean of Ceramic Magnets.pptx
Unlocking  the Potential: Deep dive into ocean of Ceramic Magnets.pptxUnlocking  the Potential: Deep dive into ocean of Ceramic Magnets.pptx
Unlocking the Potential: Deep dive into ocean of Ceramic Magnets.pptxanandsmhk
 

Kürzlich hochgeladen (20)

Orientation, design and principles of polyhouse
Orientation, design and principles of polyhouseOrientation, design and principles of polyhouse
Orientation, design and principles of polyhouse
 
Cultivation of KODO MILLET . made by Ghanshyam pptx
Cultivation of KODO MILLET . made by Ghanshyam pptxCultivation of KODO MILLET . made by Ghanshyam pptx
Cultivation of KODO MILLET . made by Ghanshyam pptx
 
CELL -Structural and Functional unit of life.pdf
CELL -Structural and Functional unit of life.pdfCELL -Structural and Functional unit of life.pdf
CELL -Structural and Functional unit of life.pdf
 
All-domain Anomaly Resolution Office U.S. Department of Defense (U) Case: “Eg...
All-domain Anomaly Resolution Office U.S. Department of Defense (U) Case: “Eg...All-domain Anomaly Resolution Office U.S. Department of Defense (U) Case: “Eg...
All-domain Anomaly Resolution Office U.S. Department of Defense (U) Case: “Eg...
 
Raman spectroscopy.pptx M Pharm, M Sc, Advanced Spectral Analysis
Raman spectroscopy.pptx M Pharm, M Sc, Advanced Spectral AnalysisRaman spectroscopy.pptx M Pharm, M Sc, Advanced Spectral Analysis
Raman spectroscopy.pptx M Pharm, M Sc, Advanced Spectral Analysis
 
Disentangling the origin of chemical differences using GHOST
Disentangling the origin of chemical differences using GHOSTDisentangling the origin of chemical differences using GHOST
Disentangling the origin of chemical differences using GHOST
 
Botany krishna series 2nd semester Only Mcq type questions
Botany krishna series 2nd semester Only Mcq type questionsBotany krishna series 2nd semester Only Mcq type questions
Botany krishna series 2nd semester Only Mcq type questions
 
Nightside clouds and disequilibrium chemistry on the hot Jupiter WASP-43b
Nightside clouds and disequilibrium chemistry on the hot Jupiter WASP-43bNightside clouds and disequilibrium chemistry on the hot Jupiter WASP-43b
Nightside clouds and disequilibrium chemistry on the hot Jupiter WASP-43b
 
Recombinant DNA technology (Immunological screening)
Recombinant DNA technology (Immunological screening)Recombinant DNA technology (Immunological screening)
Recombinant DNA technology (Immunological screening)
 
Botany 4th semester series (krishna).pdf
Botany 4th semester series (krishna).pdfBotany 4th semester series (krishna).pdf
Botany 4th semester series (krishna).pdf
 
Labelling Requirements and Label Claims for Dietary Supplements and Recommend...
Labelling Requirements and Label Claims for Dietary Supplements and Recommend...Labelling Requirements and Label Claims for Dietary Supplements and Recommend...
Labelling Requirements and Label Claims for Dietary Supplements and Recommend...
 
VIRUSES structure and classification ppt by Dr.Prince C P
VIRUSES structure and classification ppt by Dr.Prince C PVIRUSES structure and classification ppt by Dr.Prince C P
VIRUSES structure and classification ppt by Dr.Prince C P
 
GBSN - Microbiology (Unit 1)
GBSN - Microbiology (Unit 1)GBSN - Microbiology (Unit 1)
GBSN - Microbiology (Unit 1)
 
Engler and Prantl system of classification in plant taxonomy
Engler and Prantl system of classification in plant taxonomyEngler and Prantl system of classification in plant taxonomy
Engler and Prantl system of classification in plant taxonomy
 
Presentation Vikram Lander by Vedansh Gupta.pptx
Presentation Vikram Lander by Vedansh Gupta.pptxPresentation Vikram Lander by Vedansh Gupta.pptx
Presentation Vikram Lander by Vedansh Gupta.pptx
 
DIFFERENCE IN BACK CROSS AND TEST CROSS
DIFFERENCE IN  BACK CROSS AND TEST CROSSDIFFERENCE IN  BACK CROSS AND TEST CROSS
DIFFERENCE IN BACK CROSS AND TEST CROSS
 
STERILITY TESTING OF PHARMACEUTICALS ppt by DR.C.P.PRINCE
STERILITY TESTING OF PHARMACEUTICALS ppt by DR.C.P.PRINCESTERILITY TESTING OF PHARMACEUTICALS ppt by DR.C.P.PRINCE
STERILITY TESTING OF PHARMACEUTICALS ppt by DR.C.P.PRINCE
 
Broad bean, Lima Bean, Jack bean, Ullucus.pptx
Broad bean, Lima Bean, Jack bean, Ullucus.pptxBroad bean, Lima Bean, Jack bean, Ullucus.pptx
Broad bean, Lima Bean, Jack bean, Ullucus.pptx
 
GBSN - Microbiology (Unit 2)
GBSN - Microbiology (Unit 2)GBSN - Microbiology (Unit 2)
GBSN - Microbiology (Unit 2)
 
Unlocking the Potential: Deep dive into ocean of Ceramic Magnets.pptx
Unlocking  the Potential: Deep dive into ocean of Ceramic Magnets.pptxUnlocking  the Potential: Deep dive into ocean of Ceramic Magnets.pptx
Unlocking the Potential: Deep dive into ocean of Ceramic Magnets.pptx
 

Management of Pre-eclampsia and eclampsia Case discussions

  • 1. Management of Pre-eclampsia and eclampsia Case Discussions
  • 2.  BACKGROUND:  Ten percent of all pregnancies are complicated by hypertension (HTN).Eclampsia and preeclampsia account for about half of these cases worldwide.  DEFINITION: Eclampsia is defined as the clinical presentation of an unexplained seizure, convulsion, or altered mental status in the setting of the signs and symptoms of preeclampsia. It is considered a complication of severe preeclampsia.  A woman with preeclampsia develops: --- high blood pressure (>140 mmHg systolic or >90 mmHg diastolic) --- protein in the urine --- swelling (edema) of the legs, hands, face or entire body.
  • 3. A25-year old 2nd gravida with a pregnancy of 28 weeks of gestation comes for antenatal visit and on routine check up, she is found to be having blood pressure of 150/100 mm of Hg.  What is the diagnosis? Repeat blood pressure measurement should be performed after 6 hours for the diagnosis of hypertension in pregnancy.4 Urine should be checked for presence or absence of proteinuria, diagnosis of the patient will depend on the presence or absence of the proteinuria. If blood pressure is found to be same or > 140/ 90 mm of Hg on two occasions, 6 hours apart without proteinuria it is gestational hypertension
  • 4. If proteinuria (defined as the urinary excretion of 300 mg/L or more of protein in a 24 hour urine collection or > 30 mg/dl or 1+ by qualitative assessment using reagent strips) is present, it is preeclampsia, therefore proteinuria should be ruled out by testing for urine albumin. If patient gives history of pre-pregnancy high blood pressure, or has history of high blood pressure before 20 weeks of gestation during this pregnancy, the diagnosis is chronic hypertension. If blood pressure comes to normal 6 hours later by rest, patient should be observed carefully as there is high possibility of developing gestational hypertension later on in pregnancy.
  • 5. Elaborate the points in the history of hypertensive patients in pregnancy which would help in the diagnosis and management 1.Age and parity: Preeclampsia often affects young and nulliparous women; whereas older women >35 years of age are at greater risk for chronic hypertension with superimposed preeclampsia. 2.History of hypertension in family, in earlier pregnancy or prepregnancy high blood pressure: If there is history of gestational hypertension in earlier pregnancy, there are more chances of developing hypertension in this pregnancy, the incidence being 70%.The risk of developing preeclampsia is 20- 40% for daughters of preeclamptic mothers; 11-37% for sisters of preeclamptic women; and 22- 47% in twin sisters. 3.Race and ethinicity: Africans are more susceptible than caucasians 4.History of diabetes, thyroid disorder, anemia: These are related disorders. Both hypo- thyroidism and hyperthyroidism are associated with hypertension. 5.History of twins, hydramnios, H.mole: would cause earlier hypertension in this pregnancy. 6.Smoking reduces the risk of preeclampsia.
  • 6. What are the important points in examination Besides vital parameters like pulse, blood pressure, respiratory rate, temperature, urine output, pallor, pedal edema, other important points in examination are: • Height, weight and BMI of the patient: obesity is more commonly associated with preeclampsia. The relationship between maternal weight and the risk of preeclampsia is progressive. • Thyroid swelling: Any obvious fullness is to be noted and investigated. • Cardiovascular system: signs of congestive cardiac failure like basal crepitations, raised JVP, dyspnea and tachypnea have to be ruled out.
  • 7. Obstetric examination: Fundal height should correspond to the period of gestation.  Fundal height more than period of gestation suggests twins, hydramnios, molar pregnancy and these conditions are more commonly associated with hypertension in pregnancy. Fundal height less than period of gestation is suggestive of fetal growth retardation and also may be associated with hypertension or antihypertensive therapy, particularly atenolol
  • 8. . How will you manage the above patient First we will like to confirm the diagnosis of gestational hypertension . To rule out severe hypertension hospitalization is advisable at least initially for 48 hours. During this period 4 hourly blood pressure measurements with other investigations are performed. They are as follows: • Complete blood count including platelet count • Urine albumin • Liver function test • Lactate dehydrogenase (LDH) for the diagnosis of HELLP syndrome • PT and PTTK-Only if platelet count is abnormal • Fundus examination to rule out severity of the
  • 9. Urine albumin should be done daily by dipstick method. If the patient is confirmed to be mild hypertensive after investigation without any organ dysfunction, she may be allowed to go home All investigations are repeated once a week or fortnightly depending on the severity except urine albumin and blood pressure measurement which should be done daily. In addition to maternal investigations, fetal monitoring is also required. Fetal assessment includes daily fetal movement count by the patient which should be more than 10 in 24 hours or more than 3 in one hour three times a day,  non-stress test (NST), biophysical profile, umbilical artery and cerebral artery Doppler. These investigations are performed between 28-30 weeks of gestation initially and the biophysical profile/NST is repeated at least once a week till patient delivers. The frequency may increase if hypertension becomes of a severe variety or Doppler shows changes suggestive of fetal growth restriction.
  • 10. What is the role of elective cesarean delivery?  Patients with mild disease are generally allowed vaginal delivery unless there are obstetric indications for cesarean sections. Once severe preeclampsia is diagnosed, labor induction and vaginal delivery have been considered ideal. Temporization with an immature fetus is considered subsequently. Several concerns, including an unfavorable cervix, a perceived sense of urgency because of severity of preeclampsia, and the need to coordinate neonatal intensive care, have led some obstetricians to advocate cesarean delivery.
  • 11. What is the role of antihypertensive drugs? Most obstetricians would like to start antihypertensive drugs after blood pressure reaches 150/100 mm of Hg thinking that these will prevent the progression of mild disease into severe disease and also prevent the complication like severe hypertension, abruptio placentae, IUD, cardiac failure, pulmonary edema, cerebral hemorrhage. Methyldopa (aldomet) has been the most widely used antihypertensive drug during pregnancy and longest followed up. It is found to be safe from the point of view of development of children later on in life, whose mothers were administered this drug during pregnancy. It has been submitted to many controlled trials during pregnancy and has been shown to have beneficial effects. 7 The usual starting dose is 250 mg of methyldopa three times a day. This amount may be increased up to a total of 2 gm /day according to the patient’s response. The common side effects are postural hypotension, excessive sedation and depression. Positive Coombs’ test and abnormal liver test are also reported.  Calcium channel blocker like nifedipine is also being used  Labetalol is also being used but associated with intrauterine growth retardation of the fetus
  • 12. Case 2 A 32-years old multiparous woman with 32weeks of period of gestation has come to the casualty with blood pressure of 160/110 mm of Hg and complains of headache and urine albumin on dipstix is 2 +.  What is the diagnosis?  The diagnosis of this patient is more likely of severe preeclampsia with impending eclampsia. The diagnosis may also be that of severe pre- eclampsia superimposed on chronic hypertension if the patient gives history of chronic hypertension in the interval between pregnancy or before 20 weeks of the pregnancy.
  • 13. What are the additional points in the history and examination to be looked for?  history of excessive weight gain  history of headache/visual disturbances like blurring of vision, bright or black spots: suggestive of impending eclampsia  history of epigastric pain/ right upper quadrant pain  history of decreased urinary output  any history of convulsion  any history of intake of antihypertensive drugs  any history of breathlessness/chest pain/ ghabrahat etc: suggestive of impending cardiac failure/pulmonary edema  any history of renal disease
  • 14. In addition to examination points discussed inthe case1 of mild hypertension mentioned earlier, following points to be noted: 1.Reflexes: Brisk deep tendon reflexes are also common and result from central nervous system irritability. It is unusual for preeclamptic patients to have seizures without first showing signs of nervous system irritability. 2.Fundus examination: Most common findings on fundus in severe preeclampsia are: (1) increase in a vein to artery ratio and segmental vasospasm (2) The presence of hemorrhage,exudates or extensive arteriolar changes suggest chronic hypertension. (3) Papilledema is not a common finding in preeclampsia. it suggests the possibility of a brain tumor,
  • 15. Q.10. What are the main objectives of the management? The basic management objectives for any pregnancy complicated by preeclampsia are: 1.Termination of pregnancy with the least possible trauma to mother and fetus. As of now only cure for preeclampsia is the termination of pregnancy. At best, it may be controlled only when it is of mild variety. It is dangerous to continue pregnancy in severe preeclampsia for more than 1-2 weeks. 2.Birth of an infant who subsequently thrives 3.Complete restoration of health to the mother
  • 16. Q.11. What are the points of severity of the disease?
  • 17. What is the immediate management of this patient? Our aims for the immediate management of this patient are: To bring down the blood pressure to safe levels (from severe variety to moderate variety) Assess general condition for presence of immediate risk factors for convulsions (headache, altered sensorium, drowsiness,agitation, Assessment of the fetal wellbeing and reasonable maturity
  • 18.  1. Use of antihypertensive drugs, importantly intravenous labetalol or oral nifedipine. Intravenous labetalol is used in the doses of 20 mg→40 mg→80 mg→80 mg repeated every 10-20 minutes till a maximum dose of 220 mg. Oral nifedipine in the doses of 10 mg→20 mg→20 mg→20 mg→20 mg may also be used upto a maximum dose of 90 mg,with blood pressure monitoring every 10-20 minutes.8 Once the blood pressure control is achieved ( blood pressure < 160/ 110 mm of Hg) maintenance dose in the form of oral labetalol 100 mg twice a day (maximum up to 1200 mg) or methyldopa 250 mg thrice a day (maximum up to 2000 mg/day) or nifedipine 10 mg twice to thrice a day (maximum up to 80 mg) may be started. The dose of oral drug can be titrated according to the blood pressure levels.
  • 19. Use of magnesium sulphate: It is the most commonly used drug for the prevention and treatment of eclampsia. Magnesium sulphate is used as 4 gm (20% solution) of loading dose intra- venously followed by 5 gm of 50% solution intramuscularly in each buttock. Maintenance dose is 5 gm in alternate buttock 4 hourly till 24 hours after delivery
  • 20. What is the expectant management in the case of severe preeclampsia? Most obstetricians would like to terminate the pregnancy if reasonable maturity of fetus is present ( >32 weeks or >1 kg). Patient has to be treated only in a tertiary care center where facility of expert neonatologists, anaesthesiologists, senior obstetricians, O.T facility,and blood bank facility are available. In a rare case, when period of gestation is less than 28 weeks, to gain 1 or 2 weeks more, patient would be observed by extremely close monitoring that is done every 2 hourly blood pressure, urine output, general conditions (tachypnea, dyspnea, crepts in chest) monitoring and if necessary, everyday monitoring by investigations like hemogram with platelet count, Liver function test, kidney function test, PT and PTTK
  • 21. Patient in dangers 1.Patients throwing convulsions 2.HELLP syndrome ( 40% mortality) 3.Unannounced abruption and IUD 4.DIC 5.Cardiac complications like pulmonary edema 6.Fetal complications like intrauterine growth retardation, absent or reversed umbilical artery Doppler, intrauterine death, neonatal death. However, neonatal death may occur even after termination of the pregnancy.
  • 22. How do we manage a patient with eclampsia?  Check vitals  Place patient in lateral decubitus position to prevent aspiration. The bed rails should be elevated to prevent maternal injury. Padded tongue blade should be inserted between teeth to avoid injury to the tongue.  Quick history and examination.  Keep airway clean and patent by frequent oral suctioning.  Give oxygen by mask at 8-10 litres/minute, if convulsion occurs or pulse oximetry shows hypoxia  Prevent convulsions further by keeping silence,dim lights, and minimal noise  Give loading dose of magnesium sulphate, 4 gm of 20% solution intravenously slowly over 5 minutes and 5 gm of 50% solution intra- muscularly in each buttock followed by a maintenance dose of 5 gms IM in alternate buttocks every 4 hourly till 24 hours after delivery.
  • 23.  Intravenous labetalol or oral nifedipine to bring down the blood pressure to moderate level.  Pulse oximetry: There is possibility of help from anesthetists if patient is not maintaining oxygen saturation on pulse oximeter 10.After the patient is stabilized, do per vaginum examination and decide termination, preferably vaginal delivery by instilling dinoprostone gel if cervix is too unfavorable or oxytocin augmentation in higher concentration to prevent fluid overload (for primi patients 5 units in 500 ml of Ringer lactate
  • 24.  It should be noted that cesarean section in eclampsia has higher morbidity and mortality than vaginal delivery. However, indications of cesarean in eclampsia sometimes can be, though rarely  (1) obstetric indication like transverse lie, malpresentation, placenta previa, cephalo pelvic disproportion  (2) uncontrolled fits not responding to the anticonvulsants treatment and for termination of pregnancy if there is no immediate prospect of vaginal delivery inspite of induction of labor.
  • 25. What are the causes of death in eclampsia • Intracranial hemorrhage, cerebrovascular accidents • Pulmonary edema • Status eclampticus • Congestive cardiac failure • Acute renal failure/hepatic failure • Hypertensive encephalopathy • Acute tubular necrosis or cortical necrosis • Disseminated intravascular coagulation (DIC) • Hyperpyrexia due to pontine hemorrhage • ARDS • Aspiration pneumonitis • All above conditions either singly or in combination.
  • 26. What is the prognosis of the disease?  The seizure characteristics of eclampsia are acute and transient and long-term neurologic deficits are rare in patients adequately treated. However, 35% of patients who develop eclampsia will have preeclampsia in a subsequent pregnancy. However, recurrence of eclampsia is 1.4%. • In women with preeclampsia in first pregnancy, the probability of recurrence in second pregnancy is about 30% and is in inverse relation to the gestational age at which the patient developed the disease. • The incidence of chronic hypertension was significantly increased.
  • 27. What are the complications expected in this patient  : Maternal complications are: • Super imposed preeclampsia (incidence being 25%) • Development of severe hypertension.  Placental abruption  Fetal complications are: • Fetal growth restriction • Preterm delivery and perinatal mortality • Prone to developmental anomalies due to exposure to fetotoxic drugs like ACE inhibitors in early pregnancy.